quinoxalines has been researched along with dinoprost in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Q; Hauth, T; Hyman, A; Lippton, HL | 1 |
| Armstead, WM; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Flavahan, NA; Shimokawa, H; Vanhoutte, PM | 1 |
| Cambria, RA; Gloviczki, P; Lowell, RC; Miller, VM | 1 |
| Flavahan, NA | 1 |
| Mermoud, A | 1 |
| Landis, ME; Miller, VM; Ray, EC | 1 |
| Bidouard, JP; Breugnot, C; Mahlberg, F; Perrault, LP; Vanhoutte, PM; Vilaine, JP; Villeneuve, N | 1 |
| Didion, SP; Faraci, FM; Heistad, DD | 1 |
| Borsody, MK; Komuro, T; Macdonald, RL; Marton, LS; Ono, S; Paik, E; Weir, BK; Zhang, ZD | 1 |
| Phelan, P | 1 |
| Hommer, A; Kapik, B; Shams, N | 1 |
| Ishikawa, H; Ohnishi, Y; Yamaji, K; Yoshitomi, T | 1 |
| Day, DG; Jenkins, J; Stewart, JA; Stewart, WC | 1 |
| Day, DG; Henry, CJ; Jenkins, JN; Mundorf, TK; Sharpe, ED; Stewart, JA; Stewart, WC | 1 |
| Călugăru, D; Călugăru, M | 1 |
| Castillo, C; Castillo, EF; López, RM; Ortíz, CS; Ruíz, A; Vélez, JM | 1 |
| Huang, ZQ; Xu, HB | 1 |
| Majewski, H; Zhao, J | 1 |
| Kang, P; Seol, GH | 1 |
| Kang, P; Kim, HK; Lee, JM; Ryu, KH; Seol, GH | 1 |
2 review(s) available for quinoxalines and dinoprost
| Article | Year |
|---|---|
Reappraising first-line treatment in glaucoma management.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Dinoprost; Drug Therapy, Combination; Glaucoma; Humans; Latanoprost; Lipids; Prostaglandins; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Travoprost | 2002 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Drug Combinations; Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2004 |
3 trial(s) available for quinoxalines and dinoprost
| Article | Year |
|---|---|
Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chemotherapy, Adjuvant; Dinoprost; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol | 2003 |
The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cross-Over Studies; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Quinoxalines; Safety; Treatment Outcome | 2004 |
Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Dinoprost; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Quinoxalines; Timolol; Treatment Outcome | 2005 |
16 other study(ies) available for quinoxalines and dinoprost
| Article | Year |
|---|---|
Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cats; Dinoprost; GTP-Binding Proteins; Indomethacin; Methoxamine; Pertussis Toxin; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Quinoxalines; Signal Transduction; Thromboxane A2; Virulence Factors, Bordetella; Xanthines | 1992 |
Influence of nisoldipine on vascular resistance and vasoconstrictor responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction | 1987 |
Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein.
Topics: Adenosine Diphosphate; Animals; Antihypertensive Agents; Blood Platelets; Bradykinin; Brimonidine Tartrate; Calcimycin; Coronary Vessels; Dinoprost; Endothelium, Vascular; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Pertussis Toxin; Potassium Chloride; Quinoxalines; Serotonin; Swine; Thrombin; Virulence Factors, Bordetella | 1989 |
Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs.
Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic alpha-Agonists; Animals; Arginine; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Brimonidine Tartrate; Calcimycin; Constriction; Dinoprost; Dogs; Endothelins; Endothelium, Vascular; Femoral Artery; Femoral Vein; Hyperplasia; Male; Models, Biological; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Quinoxalines; Thrombin; Tunica Intima; Vascular Patency | 1994 |
Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
Topics: Adenosine Diphosphate; Animals; Bradykinin; Brimonidine Tartrate; Coronary Vessels; Dinoprost; Endothelium, Vascular; Female; Fluorides; GTP-Binding Proteins; Lysophosphatidylcholines; Male; Muscle Contraction; Pertussis Toxin; Quinoxalines; Serotonin; Signal Transduction; Swine; Virulence Factors, Bordetella | 1993 |
[Modern anti-glaucoma drugs and their secondary effects].
Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Dinoprost; Glaucoma; Humans; Quinoxalines; Sulfonamides; Thiophenes | 1998 |
Effects of dietary L-arginine on the reactivity of canine coronary arteries.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Brimonidine Tartrate; Calcimycin; Coronary Vessels; Dietary Supplements; Dinoprost; Dogs; Endothelium, Vascular; Ionophores; Male; Muscle Contraction; Muscle, Smooth; Nitric Oxide; omega-N-Methylarginine; Quinoxalines; Tetraethylammonium | 1999 |
Hypercholesterolemia increases coronary endothelial dysfunction, lipid content, and accelerated atherosclerosis after heart transplantation.
Topics: Adrenergic alpha-Agonists; Animals; Arteriosclerosis; Biological Transport; Brimonidine Tartrate; Calcimycin; Calcium; Cholesterol, HDL; Cholesterol, LDL; Coronary Vessels; Diet, Atherogenic; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythrocyte Count; Female; Free Radical Scavengers; Heart Transplantation; Hematocrit; Hemoglobins; Hypercholesterolemia; Hyperplasia; Ionophores; Male; Myocardium; Postoperative Period; Potassium Chloride; Quinoxalines; Serotonin; Swine; Transplantation, Homologous; Tunica Intima; Vasodilation | 2000 |
Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
Topics: Animals; Basilar Artery; Cerebral Arteries; Cholesterol; Diet, Atherogenic; Dinoprost; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Intracranial Arteriosclerosis; Macaca fascicularis; Male; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Papaverine; Quinoxalines; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |
The vasorelaxation of cerebral arteries by carbon monoxide.
Topics: Animals; Carbon Monoxide; Cerebral Arteries; Dinoprost; Dogs; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Muscle Contraction; Oxadiazoles; Potassium Channel Blockers; Potassium Chloride; Quinoxalines; Tetraethylammonium; Vasodilation | 2001 |
Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Antihypertensive Agents; Ciliary Arteries; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Histamine; Isometric Contraction; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle, Smooth, Vascular; Oxadiazoles; Peptides; Potassium Channels, Calcium-Activated; Quinoxalines; Rabbits; Vasodilation | 2004 |
Evidence against alpha-adrenoceptors mediating relaxation in rat thoracic aortae: alpha-agonists relaxation depends on interaction with alpha-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Azepines; Brimonidine Tartrate; Clonidine; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; Methoxamine; Nitric Oxide; Phenylephrine; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Serotonin; Vasoconstrictor Agents; Vasodilation; Yohimbine | 2006 |
Vasorelaxant effects of icariin on isolated canine coronary artery.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Coronary Vessels; Dinoprost; Dogs; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Endothelium, Vascular; Enzyme Inhibitors; Female; Flavonoids; Glyburide; Indomethacin; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxadiazoles; Oxytocics; Potassium Channel Blockers; Quinoxalines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetraethylammonium; Vasodilation | 2007 |
Endothelial nitric oxide attenuates Na+/Ca2+ exchanger-mediated vasoconstriction in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Aorta, Thoracic; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Oxadiazoles; Potassium; Prostaglandin-Endoperoxide Synthases; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Calcium Exchanger; Thiourea; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Linalool elicits vasorelaxation of mouse aortae through activation of guanylyl cyclase and K(+) channels.
Topics: Acyclic Monoterpenes; Animals; Aorta; Calcium; Calcium Chloride; Dinoprost; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Activation; Guanylate Cyclase; Male; Mice; Monoterpenes; NG-Nitroarginine Methyl Ester; Oxadiazoles; Potassium Channels; Quinoxalines; Tetraethylammonium; Vasodilation; Vasodilator Agents | 2015 |
Endothelium- and smooth muscle-dependent vasodilator effects of Citrus aurantium L. var. amara: Focus on Ca(2+) modulation.
Topics: Animals; Aorta; Calcium; Citrus; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; Extracellular Space; Guanylate Cyclase; Inositol 1,4,5-Trisphosphate Receptors; Intracellular Space; Isometric Contraction; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Oils, Volatile; Oxadiazoles; Phenylephrine; Quinoxalines; Ryanodine Receptor Calcium Release Channel; Vasodilation; Vasodilator Agents | 2016 |